Sandu Pharmaceuticals Ltd — Important, 01-10-2025: Company Update

Sandu Pharmaceuticals Limited's shareholders have approved the reappointment of M/S Swapnil J Dixit & Associates as the Secretarial Auditor. This firm will serve for a new term of five consecutive years, starting from April 01, 2025, and concluding on March 31, 2030. This decision ensures the company continues to uphold robust corporate governance standards and remains compliant with statutory audit requirements, which is crucial for transparency and investor confidence. The firm was previously the Secretarial Auditor, providing continuity in this key role.